Gujarat Inject Kerala Ltd delivers robust FY26 performance, Net Profit rises 78% YoY

Gujarat Inject (Kerala) Ltd (BSE - 524238) has announced its audited financial results for the quarter and financial year ended March 31, 2026, reporting strong growth in revenue and profitability driven by higher operational activity and improved business execution.

For FY26, the company reported revenue from operations of Rs. 36.32 crore as compared to Rs. 19.05 crore in FY25, registering a robust year-on-year growth of around 91%. Net profit for FY26 stood at Rs. 1.81 crore compared to Rs. 1.02 crore reported in the previous financial year, reflecting a growth of approximately 78%.

Strengthening its presence in the solar segment, Gujarat Inject Kerala Limited has secured multiple purchase orders for Solar PV Modules from various customers including Earthwave Technology, Perfect Renewtech and Surja Infra. The company received orders worth approximately Rs. 6.07 crore from Earthwave Technology for supply of 7,041 Solar PV Modules, Rs. 0.61 crore from Surja Infra for supply of 678 Solar PV Modules, additional orders worth Rs. 3.49 crore and Rs. 3.11 crore respectively from Earthwave Technology for supply of 4,056 and 3,645 Solar PV Modules and an order worth approximately Rs. 1.21 crore from Perfect Renewtech for supply of 1,355 Solar PV Modules. All the orders are expected to be executed by March 2026, marking a significant step in the company's diversification strategy and strengthening its presence in the renewable energy and solar solutions segment.

The proposed rebranding reflects the company's evolving business direction and its increasing focus on emerging opportunities in the solar and clean energy sector. As part of this transition, the company has initiated business expansion in Solar PV Modules and renewable energyrelated operations, positioning itself to participate in India's rapidly growing solar infrastructure market. The Company has already installed a 5MW solar project at Jakasana, Mehsana (Gujarat), further strengthening its execution capabilities and presence in the renewable energy sector.

The company delivered an exceptional performance during Q4FY26. Revenue from operations for the quarter stood at Rs. 30.70 crore as against Rs. 4.24 crore in Q4FY25. Profit after tax for Q4FY26 increased significantly to Rs. 1.64 crore compared to Rs. 0.07 crore reported in the corresponding quarter last year.

Profit before tax for FY26 stood at Rs. 2.50 crore compared to Rs. 1.25 crore in FY25, while earnings per share (EPS) improved to Rs. 1.24 from Rs. 0.70 in the previous year.

Mr. Deepak Diwan Bachwani, Executive Director, Gujarat Inject Kerala Limited, said, "FY26 has been a strong growth year for the company with significant improvement in both revenues and profitability. The sharp increase in operational activity reflects our focused execution strategy, strengthening business relationships and improved operational efficiencies. We have also focused on expanding our operational scale and strengthening our infrastructure to support future growth opportunities."

He further added, "We remain focused on sustaining growth momentum through disciplined execution, operational efficiency and business expansion initiatives. With improving financial performance and stronger business fundamentals, we believe the company is well positioned to create long-term value for stakeholders."

During FY26, the company reported a substantial increase in total assets, which stood at Rs. 36.67 crore as on March 31, 2026, compared to Rs. 11.95 crore in the previous year, reflecting strengthening of operational scale and infrastructure investments undertaken during the year.

The Board of Directors, at its meeting held on May 20, 2026, approved the audited standalone financial results for FY26. The statutory auditors, M/s. S. Mandawat & Co., issued an unmodified audit opinion on the financial statements.

As part of its strategic business transformation and expanding focus on emerging growth sectors including renewable energy and solar solutions, Gujarat Inject Kerala Limited has received approval for change of its name to REGENOVA RENEWTECH LIMITED, along with consequential alterations in the Memorandum of Association (MoA) and Articles of Association (AoA) of the company. The proposed name change reflects the company's evolving business vision, broader operational outlook and long-term strategy to strengthen its presence across diversified and future-oriented business segments.

Shares of Gujarat Inject Kerala Limited was last trading in BSE at Rs. 107.20 as compared to the previous close of Rs. 102.10. The total number of shares traded during the day was 19904 in over 50 trades.

The stock hit an intraday high of Rs. 107.20 and intraday low of 105.80. The net turnover during the day was Rs. 2132182.00.

Source : Equity Bulls

Keywords

INE659F01014 GujaratInjectKerala Pharmaceuticals Q4FY26 Q4FY2026 FY26 FY2026 ResultUpdate